Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Cancer Immunology, Immunotherapy : CII|November 29, 2019
Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapyNadia Mensali, Marit Renée Myhre, Pierre Dillard, et al.
Acta Oncologica (Stockholm, Sweden)|December 27, 2019
Immune stimulatory effect of anti-EpCAM immunotoxin - improved overall survival of metastatic colorectal cancer patientsYvonne Andersson, Else Marit Inderberg, Gunnar Kvalheim, et al.
BMC Biotechnology|June 4, 2020
Colorectal cysts as a validating tool for CAR therapyPierre Dillard, Maren Lie, Elizabeth Baken, et al.
The Journal of Biological Chemistry|November 25, 2020
Combinatorial CAR design improves target restrictionHakan Köksal, Pierre Dillard, Asta Juzeniene, et al.
Cancer Immunology, Immunotherapy : CII|April 10, 2017
Phase I/IIa clinical trial of a novel hTERT peptide vaccine in men with metastatic hormone-naive prostate cancerWolfgang Lilleby, Gustav Gaudernack, Paal F Brunsvig, et al.
Scientific Reports|September 8, 2017
A TCR-based Chimeric Antigen ReceptorEven Walseng, Hakan Köksal, Ibrahim M Sektioglu, et al.
Journal for Immunotherapy of Cancer|October 29, 2021
Peptide vaccine targeting mutated <i>GNAS</i>: a potential novel treatment for pseudomyxoma peritoneiKjersti Flatmark, Annette Torgunrud, Karianne G Fleten, et al.
STAR Protocols|December 14, 2024
Protocol for the development of a bioluminescent AML-PDX mouse model for the evaluation of CAR T cell therapyMireia Mayoral Safont, Calum Leitch, Mihaela Popa, et al.
Pageof 6